Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ODC1 | P11926 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24195749 | 0.94 | THRB (0.35) | CYP3A4THRBCES1TSHR | |
| SCHEMBL15146724 | 0.87 | ODC1 (0.36) | CYP3A4ODC1 | |
| SCHEMBL6885240 | 0.87 | THRB (0.40) | CYP3A4THRBCES1TSHRODC1 | |
| SCHEMBL12201021 | 0.87 | CYP3A4 (0.38) | CYP3A4THRBCES1TSHRODC1 | |
| SCHEMBL8966981 | 0.83 | TSHR (0.38) | THRBCES1TSHR | |
| SCHEMBL13039015 | 0.83 | TSHR (0.48) | CYP3A4THRBCES1TSHR | |
| SCHEMBL20416501 | 0.83 | CYP3A4 (0.42) | CYP3A4THRBCES1TSHR | |
| SCHEMBL8035913 | 0.83 | THRB (0.47) | THRB | |
| SCHEMBL8087527 | 0.82 | CYP4F2 (0.39) | THRBCES1TSHR | |
| SCHEMBL1248343 | 0.82 | TSHR (0.46) | CYP3A4THRBCES1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257507-A1 | FUNCTIONALIZED THERMOPLASTIC POLYURETHANE, METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING HIGHLY FUNCTIONAL MEDICAL COMPOSITE MATERIAL USING SAME, AND MEDICAL DEVICE INCLUDING SAME | I-SENS, INC. (KR) | 2023-08-17 | — | — | US | disclosed |
| EP-4180476-A1 | FUNCTIONALIZED THERMOPLASTIC POLYURETHANE, METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING HIGHLY FUNCTIONAL MEDICAL COMPOSITE MATERIAL USING SAME, AND MEDICAL DEVICE INCLUDING SAME | I-SENS, INC. (KR) | 2023-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257507-A1 | FUNCTIONALIZED THERMOPLASTIC POLYURETHANE, METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING HIGHLY FUNCTIONAL MEDICAL COMPOSITE MATERIAL USING SAME, AND MEDICAL DEVICE INCLUDING SAME | NOTUM, PFAS, ESD | CYP3A4 1941/4885THRB 4459/4885CES1 1557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.